Integrative Nursing Management of Cognitive Impairment

2014 ◽  
pp. 300-313
Author(s):  
Rebecca L. Ross ◽  
Iris R. Bell
Keyword(s):  
Cognitive Impairment ◽  
Cognitive Disorders ◽  
Cognitive Disorder ◽  
Integrative Approach ◽  
Nursing Management ◽  
Pharmacological Agents ◽  
The Individual ◽  
Biomedical Treatment ◽  
Reducing Stress

Cognitively impaired individuals are often sensitive to the side effects of pharmacological agents, a mainstay of biomedical treatment in this condition. An integrative approach to cognitive impairment that employs therapeutic strategies that can minimize polypharmacy while supporting improved brain function is clinically essential. Integrative interventions for cognitive disorders are dependent on the etiology or type of cognitive disorder that is being treated. Integrative nurses also recognize that family caregivers have tremendous burden when with this condition. Therefore, integrative nurses work with both the individual and caregiver, with the goal of improving overall quality of life, reducing stress and improving function.

scholarly journals Quality of life in people living with HIV-associated neurocognitive disorder: A scoping review study

PLoS ONE ◽  
2021 ◽  
Vol 16 (5) ◽  
pp. e0251944
Author(s):  
Kate Alford ◽  
Stephanie Daley ◽  
Sube Banerjee ◽  
Jaime H. Vera
Keyword(s):  
Quality Of Life ◽  
Cognitive Impairment ◽  
Scoping Review ◽  
Chronic Conditions ◽  
Healthy Aging ◽  
Cognitive Disorder ◽  
World Health ◽  
People Living With Hiv ◽  
Living With Hiv

Quality of life (QoL) is recognized as an essential end point in the disease management of chronic conditions such as HIV with calls to include good QoL as a ‘fourth 90’ in the 90-90-90 testing and treatment targets introduced by World Health Organization in 2016. Cognitive impairments impact a broad spectrum of experiences and are a common issue effecting people living with HIV (PLWH). Despite this, few studies have examined QoL in PLWH who also have a cognitive disorder. This study aimed to synthesize and describe what is known about QoL in those living with HIV-associated neurocognitive disorders (HAND). A scoping review of peer-reviewed literature was conducted to identify how QoL has been investigated and measured in PLWH with HAND, and how PLWH with HAND report and describe their QoL. We searched PsychInfo, Medline, Scopus, and Web of Science along with hand-searching reference lists from relevant studies found. Included studies were those published in English after 1st January 2003 which included PLWH with cognitive impairment not due to other pre-existing conditions. Fifteen articles met criteria for inclusion. Two studies measured QoL as a primary aim, with others including QoL assessment as part of a broader battery of outcomes. The MOS-HIV and SF-36 were the most commonly used measures of overall QoL, with findings generally suggestive of poorer overall QoL in PLWH with HAND, compared to PLWH without cognitive impairment. Studies which examined dimensions of QoL focused exclusively on functionality, level of independence, and psychological QoL domains. There is a considerable dearth of research examining QoL in PLWH with HAND. The initiatives which advocate for healthy aging and improved QoL in PLWH must be extended to include and understand the experiences those also living with cognitive impairment. Research is needed to understand the broad experiential impacts of living with these two complex, chronic conditions, to ensure interventions are meaningful to patients and potential benefits are not missed.

scholarly journals Features of diagnosis of cognitive disorders in patients with chronic brain ischemia

2016 ◽  
pp. 8-11
Author(s):  
N.P. Pavliuk
Keyword(s):  
Quality Of Life ◽  
Health Care ◽  
Cognitive Impairment ◽  
Cognitive Disorders ◽  
Chronic Ischemia ◽  
Modern Health Care ◽  
Chronic Brain Ischemia ◽  
The Many ◽  
The Brain

One of the major problems in modern health care are cerebrovascular disease, which occupy a leading place in the structure of mortality and disability in the population. Among the many clinical features of chronic ischemia of the brain is a key manifestation of cognitive impairment that often determine the severity of condition and quality of life of the patient and his relatives. Diagnosis of cognitive impairment is very important, as the timely appointment of therapy may prevent or at least delay the development of dementia.

scholarly journals Use and understanding of functional cognitive disorder terminology in United Kingdom clinical practice - a survey

BJPsych Open ◽  
2021 ◽  
Vol 7 (S1) ◽  
pp. S277-S277
Author(s):  
Alexandra Nash ◽  
Jon Stone ◽  
Alan Carson ◽  
Craig Ritchie ◽  
Laura McWhirter
Keyword(s):  
United Kingdom ◽  
Cognitive Impairment ◽  
Clinical Practice ◽  
Mild Cognitive Impairment ◽  
Old Age ◽  
Cognitive Disorders ◽  
Cognitive Disorder ◽  
Cognitive Symptoms ◽  
Case Study Methodology ◽  
Case Vignettes

AimsThis study aimed to explore the terms used by old-age psychiatrists and psychologists to describe subjective and mild cognitive impairment and functional cognitive disorders (FCD) in clinical practice.MethodParticipants were selected from across the United Kingdom based on their clinical involvement in the assessment of cognitive complaints. 9 old-age psychiatrists and 4 psychologists were interviewed about their use of terminology in clinical practice and their awareness and understanding of FCD terminology via semi-structured interview questions and case vignettes. Interviews were conducted between December 2020 and February 2021 using online platforms Zoom and Microsoft Teams. Participants were recruited by email and Twitter. All questions were asked verbally; however, the four case vignettes were displayed via screen-share. All discussions and answers were transcribed and transcripts were coded manually using the exploratory case study methodology in order to identify themes in participants’ responses.ResultThis study has highlighted the variable use of terms used to describe and diagnose patients presenting with symptoms of cognitive disorders. The terms ‘mild cognitive impairment’, ‘subjective cognitive decline’ and ‘functional cognitive disorder’ were used most commonly amongst participants, though the terms ‘subjective cognitive impairment’ and ‘pseudodementia’ were also presented. This theme of language discontinuity is underscored by participants’ varying use of terminology when describing or presenting their diagnoses for the case vignettes. The data also reveals a sub-theme of variability in application of the term FCD. Whilst all participants gave similar definitions for this term, the application of FCD as a diagnosis in practice was inconsistent. Six participants described FCD as associated with or secondary to other functional or psychiatric conditions, four participants viewed FCD as an isolated diagnosis, and one participant considered FCD to be either part of another illness or a separate diagnosis. Two participants neither used nor recognised the term FCD.ConclusionIt is evident that there is varied use of terms describing or diagnosing forms of cognitive symptoms. The findings of this study highlight the need for a clear, adoptable definition of FCD in practice as well as implementable management plans for FCD patients. This is critical in order to avoid misdiagnosis and mismanagement, which may have harmful effects on patients living with debilitating cognitive symptoms.

scholarly journals Cognitive Impairment in Multiple Sclerosis

Folia Medica ◽  
2016 ◽  
Vol 58 (3) ◽  
pp. 157-163 ◽  
Author(s):  
Anastasiya G. Trenova ◽  
Georgi S. Slavov ◽  
Maria G. Manova ◽  
Jana B. Aksentieva ◽  
Lyuba D. Miteva ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Cognitive Impairment ◽  
Cognitive Disorders ◽  
Social Burden ◽  
Immune Mediated ◽  
The Social ◽  
The Central Nervous System ◽  
Axonal Transection ◽  
The Relationship

Abstract Multiple sclerosis (MS) is a socially significant immune-mediated disease, characterized by demyelination, axonal transection and oligodendropathy in the central nervous system. Inflammatory demyelination and neurodegeneration lead to brain atrophy and cognitive deficit in up to 75% of the patients. Cognitive dysfunctions impact significantly patients’ quality of life, independently from the course and phase of the disease. The relationship between pathological brain findings and cognitive impairment is a subject of intensive research. Summarizing recent data about prevalence, clinical specificity and treatment of cognitive disorders in MS, this review aims to motivate the necessity of early diagnosis and complex therapeutic approach to these disturbances in order to reduce the social burden of the disease.

scholarly journals Cognitive Skills Questionnaire: Comparative Results in Elderly Population without Cognitive Deficit, Mild Cognitive Impairment and Alzheimer's Disease

2020 ◽  
pp. 1-8
Author(s):  
Edith Labos ◽  
Edith Labos ◽  
Sofia Trojanowski ◽  
Karina Zabala ◽  
Miriam Del Rio ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Cognitive Skills ◽  
Cognitive Disorders ◽  
Cognitive Disorder ◽  
Screening Tools ◽  
Control Group ◽  
Cognitive Complaint

The increase in consultations for changes and/or cognitive complaints in the elderly, together with the current interest in epidemiological research in this context creates the need for screening tools for cognitive assessment to enable the detection of early deficits. Evidence shows its predictive value in the development of dementia disease. This study aims at displaying the results of a Cognitive Skills Questionnaire (CSQ) in a patient population with mild cognitive impairment (MCI) and Alzheimer’s disease (AD), both compared with a control group (CG) with no cognitive disorder and verifying its sensitivity and specificity in order to identify risk patients with cognitive disorder. Participants and Methods: A total of 208 participants were evaluated, out of which 60 had MCI, 46 had AD and a remaining group of 102 subjects who had no cognitive disorder. All participants were administrated the CSQ and a battery of neuropsychological proofs. We analysed the statistical data using ANOVA, Student’s t-test, Tuckey test, ROC curve and principal components analysis. A multiple regression analysis was carried out so as to single out those questions which better differentiated the studied groups. Results: The CSQ showed significant differences between the CG and both groups of patients (AD p> 0.01 and MCI p> 0.05). It was established a cut-off point of 17.5 in the CSQ total score with a sensitivity of 93% and a specificity of 91.3%. Conclusion: The CSQ could eventually allow us to identify patients with cognitive disorders and those others with a cognitive complaint greater than expected. Thus, this questionnaire could be a useful testing and counselling tool in health primary attention.

Integrative Nursing Management of Sleep

2018 ◽  
pp. 206-220
Author(s):  
Norma G. Cuellar
Keyword(s):  
Chronic Health Conditions ◽  
Health Conditions ◽  
Integrative Approach ◽  
Health Indicator ◽  
Nursing Management ◽  
Chronic Health ◽  
Mortality And Morbidity ◽  
Sleep Assessment ◽  
Quality Sleep

Sleep, either too much or not enough, has been shown to increase mortality and morbidity when associated with chronic health conditions. The importance of sleep assessment and management in acute and chronic health conditions has been highly underrepresented and ignored as a health indicator. This chapter describes an integrative approach to sleep assessment, including commonly used measures and biomarkers. Evidence supports the use of integrative approaches to facilitate restful, high-quality sleep that can not only improve health outcomes but can also improve quality of life in persons across the lifespan.

Cognitive impairment in patients with epilepsy and effectiveness of overcoming stress behavior

2016 ◽  
Vol 33 (S1) ◽  
pp. S369-S369
Author(s):  
V. Korostiy ◽  
B. Gerasimov
Keyword(s):  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Cognitive Disorders ◽  
Psychological Characteristics ◽  
The Social ◽  
Therapeutic Measures ◽  
Competing Interest ◽  
Patients With Epilepsy ◽  
Addenbrooke’S Cognitive Examination

IntroductionToday cognitive impairment study epilepsy in children and in people taking anticonvulsants. Unfortunately, we do not know enough about neuropsychological features of mild cognitive impairment in epilepsy, clinical and pathogenetic patterns of their development, role in the development of social exclusion.AimTo study the mild cognitive impairment and their relationship with clinical features of epileptic disease forms, socio-psychological characteristics of patients.MethodsClinical-psychopathological, psychodiagnostic.ResultsWe first used Addenbrooke's cognitive examination (ACE-R) in patients with epilepsy to quantify cognitive disorders in this group. The specified scale detects violations of cognitive function to mild dementia and allows us to differentiate the prevalence of certain disorders of mental processes. We revealed that the reducing the effectiveness of stress overcoming behavior through cognitive disorders in thinking and attention are one of the pathognomonic psychogenic mechanisms of affective disorders in patients with epilepsy. The complex of individual therapeutic measures for patients with epilepsy and MCI is based on the study features of cognitive disorders results. Psychotherapy and psychological correction measures for patients with epilepsy and MCI have to improve the social functioning and quality of life. We also created recommendations for the prevention of cognitive disorders in patients with epilepsy.ConclusionsThe features of cognitive disorders in patients with epilepsy, depending on the clinical form of epilepsy (symptomatic, idiopathic, cryptogenic). It should be used as additional differential diagnostic criteria forms of epilepsy (symptomatic, idiopathic, cryptogenic).Disclosure of interestThe authors have not supplied their declaration of competing interest.

Association between metabolic syndrome and cognitive decline: a systematic review of prospective population-based studies

2011 ◽  
Vol 23 (2) ◽  
pp. 69-74 ◽  
Author(s):  
Zilong Hao ◽  
Bo Wu ◽  
Deren Wang ◽  
Ming Liu
Keyword(s):  
Metabolic Syndrome ◽  
Cognitive Impairment ◽  
Cognitive Decline ◽  
Vascular Dementia ◽  
Cognitive Disorders ◽  
Fold Increase ◽  
Population Based ◽  
Individual Risk ◽  
The Individual ◽  
Positive Results

Objective: The association between metabolic syndrome (MS) and the risk of cognitive impairment or dementia remains unclear. In this article, we systematically review studies on the risk of cognitive disorders in patients with MS to determine the strength of the association between MS and cognitive decline.Methods: Electronic databases through December 2009 were searched to identify prospective population-based studies that examined the association between MS and risk of cognitive disorders. Two reviewers used a standardised form to collect data and assess eligibility. The quality of study was assessed by the Newcastle–Ottawa Scale.Results: We found nine eligible studies that involve 19 876 participants. All studies but two indicate that MS is associated with cognitive decline (from one-fold to more than two-fold increase in risk). It seems that MS may be associated with cognitive impairment (positive results in three of five) and vascular dementia (positive results in two of three), whereas three studies involving patients with Alzheimer's disease (AD) did not find the association between MS and AD. When examining the association of the individual risk factors of the MS and cognition in seven eligible studies, glucose (three studies) and hypertension (three studies) showed positive results associated with cognitive decline.Conclusion: The MS may be associated with cognitive impairment and vascular dementia but not for AD, which need to be further investigated with high-quality studies.

Integrative Nursing Management of Nausea

2018 ◽  
pp. 185-205
Author(s):  
Susanne M. Cutshall ◽  
Lisa M. VanGetson
Keyword(s):  
Quality Of Life ◽  
Medical Care ◽  
Nursing Practice ◽  
Vital Role ◽  
Integrative Approach ◽  
Medical Complications ◽  
Evidence Based ◽  
Nursing Management ◽  
Delayed Recovery

This chapter provides an overview of the background for nausea and the evidence-based integrative approaches for assessment, prevention, and management of nausea and vomiting. Nausea and subsequent vomiting are common symptoms that patients may experience with medical conditions and treatments. There are many causes for nausea including medication and specific conditions and procedures. Nausea can be unpleasant and lead to other medical complications, delayed recovery, and increased medical costs; affect the quality of life and satisfaction with medical care; and contribute to future anticipatory nausea and anxiety with medical care. A multimodal integrative approach to management of nausea is often needed. Nurses trained in integrative nursing practice can play a vital role in assisting patients with strategies to prevent, treat, and manage nausea. This chapter reviews an example of clinical application of these strategies utilizing an integrative nursing approach.

scholarly journals New analytical tools and frameworks to understand dementia: what can a human rights lens offer?

2020 ◽  
pp. 1-10
Author(s):  
Suzanne Cahill
Keyword(s):  
Human Rights ◽  
Treatment Process ◽  
Medical Model ◽  
Cognitive Disorder ◽  
Policy Makers ◽  
The Individual ◽  
Rights Issue ◽  
Analytical Tools ◽  
Underlying Pathology

Abstract The biomedical model has traditionally informed the dominant discourse on dementia and has significantly shaped practitioners’, policy makers’ and researchers’ responses. This model contextualises dementia as a progressive neuro-degenerative cognitive disorder and focuses on deficits and underlying pathology, often overlooking the fact that the person can and should be an active partner in the treatment process. Beginning in the late 1990s, the exclusive reliance on the bio-medical model has come under increasing scrutiny with a growing awareness that by recasting dementia in broader social and more humanitarian terms, much can be done to promote the individual's quality of life. Different frameworks and analytical tools have been forwarded to help us better understand dementia. These include personhood, citizenship, public health, disability and human rights. This review examines the merits of framing dementia as a disability, a citizenship concern and a human rights issue. It highlights some of the potential gains that can arise for the individual in using a human rights model to enhance practice, inform policy and create a more balanced research agenda. The article concludes by arguing that the complexities and magnitude of dementia are such that it requires multiple responses and a broad range of interpretative frameworks.

Sign in / Sign up

Export Citation Format

Share Document